Related content

Polymorphisms in the Methylenetetrahydrofolate Reductase Gene: Clinical Consequences

By Schwahn B.   Rozen R.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 3, 2001-01 ,pp. : 189-201

Adis International

Access to resources Recommend Favorite

&bgr;₂-adrenergic receptor polymorphisms and asthma in the North Indian population

By Bhatnagar Pallav   Gupta Simone   Guleria Randeep   Kukreti Ritushree  

Pharmacogenomics, Vol. 6, Iss. 7, 2005-10 ,pp. : 713-719

Future Medicine

Access to resources Recommend Favorite

&bgr;₂-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics^∗

By Kukreti Ritushree   Bhatnagar Pallav   B-Rao Chandrika   Gupta Simone   Madan Babita   Das Chinmoyee   Guleria Randeep   Athavale Amita Umesh   Brahmachari Samir Kumar   Ghosh Balaram  

Pharmacogenomics, Vol. 6, Iss. 4, 2005-06 ,pp. : 399-410

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphisms, their allele combinations and IFN-&bgr;β treatment response in Irish multiple sclerosis patients

By O’’Doherty Catherine   Favorov Alexander   Heggarty Shirley   Graham Colin   Favorova Olga   Ochs Michael   Hawkins Stanley   Hutchinson Michael   O’’Rourke Killian   Vandenbroeck Koen  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1177-1186

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of the response to &bgr;β2 agonist drugs: a systematic overview of the field

By Contopoulos-Ioannidis Despina G   Kouri Ioanna   Ioannidis John PA  

Pharmacogenomics, Vol. 8, Iss. 8, 2007-08 ,pp. : 933-958

Future Medicine

Access to resources Recommend Favorite